CESCA THERAPEUTICS INC. FIRST AMENDED AND RESTATED NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • April 18th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This First Amended and Restated Nomination and Voting Agreement (this “Agreement”) is made as of April 16, 2018 by and between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and Boyalife (Hong Kong) Limited (“Investor”). The Company and the Investor are referred to herein collectively as, the “Parties”. This Agreement amends and restates that certain Nomination and Voting Agreement originally entered into by the Parties and Boyalife Investment Inc. (“Boyalife USA”) on February 13, 2016 (the “Original Agreement”).
First Amended and Restated Revolving Credit AgreementRevolving Credit Agreement • April 18th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
THIS FIRST AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of April 16, 2018 (the “Effective Date”), is made between CESCA THERAPEUTICS INC., a Delaware corporation (“Borrower”), and BOYALIFE ASSET HOLDING II, INC., an Illinois corporation (the “Lender”) and the successor-in-interest by merger of Boyalife Investment Fund II, Inc. (“Predecessor”). This Agreement amends and restates that Revolving Credit Agreement, dated March 6, 2017, previously entered into by Borrower and Predecessor, as amended by Amendment No. 1 thereto dated September 13, 2017 (the “Prior Agreement”).
